Common use of Patent No Clause in Contracts

Patent No. Australia 23244/88 Issued 632,462 Austria EP 88907510.7 Granted EP/0371998 Belgium EP 88907510.7 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) France EP 88907510.7 Granted EP/0371998 Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0000000 Japan 506481/88 Pending Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 * Cases abandoned in favor of a continuing application.

Appears in 1 contract

Samples: Royalty Purchase Agreement (Xoma LTD /De/)

AutoNDA by SimpleDocs

Patent No. Germany EP 86900983.7 Granted P3689598.9-08 Italy BP 86900983.7 Granted EP/0211047 Luxembourg EP 86900983.7 Granted EP/0211047 Netherlands EP 86900983.7 Granted EP/0211047 Sweden EP 86900983.7 Granted EP/0211047 Switzerland/Liechtenstein EP 86900983.7 Granted EP/0211047 United Kingdom EP 86900983.7 Granted EP/0211047 Finland 863891 Granted 00000 Xxxxx 500818/86 Granted 0000000 Xxxxx 094753/94 Granted 2121896 Norway 863806 Granted 175870 *United States 06/695,309 *United States 06/797,472 United States 07/474,304 Granted 5,028,530 Title: Novel Plasmid Vector with Pectate Lyase Signal Sequence Inventors: Lei, Xxxxxx Based on U.S. Application No. 07/142,039 filed January 11, 1988 and PCT/US89/00077 COUNTRY SERIAL NO. PATENT NO. Australia 23244/88 Issued 632,462 29377/89 Granted 627,443 Canada 587,885 Granted 1,338,807 Europe EP 89901763.6 Granted EP/0396612 Austria EP 88907510.7 89901763.6 Granted EP/0371998 EP/0396612 Belgium EP 88907510.7 89901763.6 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) EP/0396612 France EP 88907510.7 89901763.6 Granted EP/0371998 EP/0396612 Germany EP 88907510.7 89901783.6 Granted EP/0371998 EP/0396612 Italy EP 88907510.7 89901763.6 Granted EP/0396612 Luxembourg EP 89901763.6 Granted EP/0396612 Netherlands EP 89901763.6 Granted EP/0396612 Sweden EP 89901763.6 Granted EP/0396612 Switzerland/Liechtenstein EP 89901763.6 Granted EP/0396612 United Kingdom EP 69901763.6 Granted EP/0000000 Japan 506481/88 Pending Luxembourg EP 88907510.7 501661189 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 2,980,626 *United States 07/077,528 07/142,039 * Cases abandoned in favor of a continuing application.. SCHEDULE 2.2

Appears in 1 contract

Samples: License Agreement (Affimed Therapeutics B.V.)

Patent No. Australia 23244/88 Issued 632,462 Europe EP 86900983.7 Granted EP 0211047 Austria EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Belgium EP 88907510.7 86900983.7 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 0000000 Xxxxxx EP 86900983.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) France EP 88907510.7 Granted EP/0371998 0211047 Germany EP 88907510.7 86900983.7 Granted EP/0371998 P3689598.9-08 Italy EP 88907510.7 86900983.7 Granted EP/0000000 Japan 506481/88 Pending EP 0211047 Luxembourg EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Netherlands EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Sweden EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Switzerland/ Liechtenstein EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 United Kingdom EP 88907510.7 86900983.7 Granted EP/0371998 Europe EP 93100041.8 0211047 Finland 863891 Granted EP/0550400 Austria EP 93100041.8 00000 Xxxxx 500818/86 Granted EP/0550400 Belgium EP 93100041.8 0000000 Xxxxx 094753/94 Granted EP/0550400 France EP 93100041.8 2121896 Norway 863806 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 175870 *United States 07/077,528 06/695,309 *United States 06/797,472 United States 07/474,304 Granted 5,028,530 * Cases abandoned in favor of a continuing application.. Title: Novel Plasmid Vector with Pectate Lyase Signal Sequence Inventors: Lei, Xxxxxx Based on U.S. Application No. 07/142,039 filed January 11, 1988 and PCT/US89/00077. COUNTRY APPLICATION NO. PATENT NO. Australia 29377/89 Issued/627443 Canada 587,885 1,338,807 Europe EP 89901763.6 Granted EP 0396612 Austria EP 89901763.6 Granted EP 0396612 Belgium EP 89901763.6 Granted EP 0000000 Xxxxxx EP 89901763.6 Granted EP 0396612 Germany EP 89901763.6 Granted 689 26 882 T2 Italy EP 89901763.6 Granted EP 0396612 Luxembourg EP 89901763.6 Granted EP 0396612 Netherlands EP 89901763.6 Granted EP 0396612 Sweden EP 89901763.6 Granted EP 0396612 Switzerland/ Liechtenstein EP 89901763.6 Granted EP 0396612 United Kingdom EP 89901763.6 Granted EP 0000000 Xxxxx 501661/89 Granted 2980626 *United States 07/142,039 United States 08/472,696 5,846,818 United States 08/357,234 5,576,195 * Cases abandoned in favor of a continuing application. SCHEDULE 2.2 Transfer of XOMA Materials [*] SCHEDULE 2.9 Third Parties and Activities [*] SCHEDULE 3.3 Dyax Materials [*] SCHEDULE 5.2 Redacted Agreement

Appears in 1 contract

Samples: License Agreement (Xoma LTD /De/)

Patent No. Australia 23244/88 Issued 632,462 Austria EP 88907510.7 Granted EP/0371998 Belgium EP 88907510.7 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Granted 1,341,235 Dxxxxxx 000/00 Pending Europe EP 88907510.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) Granted EP/0731167 France EP 88907510.7 Granted EP/0371998 Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0000000 Japan 506481/88 Pending Granted 2000000 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 * Cases abandoned in favor of a continuing application.07/077,528

Appears in 1 contract

Samples: Product Sublicense Agreement (Immune Pharmaceuticals Inc)

Patent No. Germany EP 86900983.7 Granted P3689598.9-08 Italy BP 86900983.7 Granted EP/0211047 Luxembourg EP 86900983.7 Granted EP/0211047 Netherlands EP 86900983.7 Granted EP/0211047 Sweden EP 86900983.7 Granted EP/0211047 Switzerland/Liechtenstein EP 86900983.7 Granted EP/0211047 United Kingdom EP 86900983.7 Granted EP/0211047 Finland 863891 Granted 00000 Xxxxx 500818/86 Granted 0000000 Xxxxx 094753/94 Granted 2121896 Norway 863806 Granted 175870 *United States 06/695,309 *United States 06/797,472 United States 07/474,304 Granted 5,028,530 Title: Novel Plasmid Vector with Pectate Lyase Signal Sequence Inventors: Lei, Xxxxxx Based on U.S. Application No. 07/142,039 filed January 11, 1988 and PCT/US89/00077 COUNTRY SERIAL NO. PATENT NO. Australia 23244/88 Issued 632,462 29377/89 Granted 627,443 Canada 587,885 Granted 1,338,807 Europe EP 89901763.6 Granted EP/0396612 Austria EP 88907510.7 89901763.6 Granted EP/0371998 EP/0396612 Belgium EP 88907510.7 89901763.6 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) EP/0396612 France EP 88907510.7 89901763.6 Granted EP/0371998 EP/0396612 Germany EP 88907510.7 89901783.6 Granted EP/0371998 EP/0396612 Italy EP 88907510.7 89901763.6 Granted EP/0396612 Luxembourg EP 89901763.6 Granted EP/0396612 Netherlands EP 89901763.6 Granted EP/0396612 Sweden EP 89901763.6 Granted EP/0396612 Switzerland/Liechtenstein EP 89901763.6 Granted EP/0396612 United Kingdom EP 69901763.6 Granted EP/0000000 Japan 506481/88 Pending Luxembourg EP 88907510.7 501661189 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 2,980,626 *United States 07/077,528 07/142,039 * Cases abandoned in favor of a continuing application.. Exhibit 10.1 SCHEDULE 2.2

Appears in 1 contract

Samples: License Agreement (Affimed Therapeutics B.V.)

Patent No. Australia 23244/88 Issued 632,462 Austria EP 88907510.7 Granted EP/0371998 Belgium EP 88907510.7 Granted EP/0371998 Canada 572,398 Pending Granted 1,341,235 Denmark 192/90 Pending Europe EP 88907510.7 XX 00000000.0 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) Granted EP/0731167 France EP 88907510.7 Granted EP/0371998 Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0000000 EP/0371998 Japan 506481/88 Pending Granted 2000000 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 * Cases abandoned in favor of a continuing application.EP/0550400

Appears in 1 contract

Samples: License Agreement (Xoma LTD /De/)

AutoNDA by SimpleDocs

Patent No. Australia 23244/88 Issued 632,462 Europe EP 86900983.7 Granted EP 0211047 Austria EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Belgium EP 88907510.7 86900983.7 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 0000000 Xxxxxx EP 86900983.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) France EP 88907510.7 Granted EP/0371998 0211047 Germany EP 88907510.7 86900983.7 Granted EP/0371998 P3689598.9-08 Italy EP 88907510.7 86900983.7 Granted EP/0000000 Japan 506481/88 Pending EP 0211047 Luxembourg EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Netherlands EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Sweden EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 Switzerland/ Liechtenstein EP 88907510.7 86900983.7 Granted EP/0371998 EP 0211047 United Kingdom EP 88907510.7 86900983.7 Granted EP/0371998 Europe EP 93100041.8 0211047 Finland 863891 Granted EP/0550400 Austria EP 93100041.8 00000 Xxxxx 500818/86 Granted EP/0550400 Belgium EP 93100041.8 0000000 Xxxxx 094753/94 Granted EP/0550400 France EP 93100041.8 2121896 Norway 863806 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 175870 *United States 07/077,528 * 06/695,309 *United States 06/797,472 United States 07/474,304 Granted 5,028,530 *Cases abandoned in favor of a continuing application.. Title: Novel Plasmid Vector with Pectate Lyase Signal Sequence Inventors: Lei, Xxxxxx Based on U.S. Application No. 07/142,039 filed January 11, 1988 and PCT/US89/00077. COUNTRY APPLICATION NO. PATENT NO. Australia 29377/89 Issued/627443 Canada 587,885 1,338,807 Europe EP 89901763.6 Granted EP 0396612 Austria EP 89901763.6 Granted EP 0396612 Belgium EP 89901763.6 Granted EP 0000000 Xxxxxx EP 89901763.6 Granted EP 0396612 Germany EP 89901763.6 Granted 689 26 882 T2 Italy EP 89901763.6 Granted EP 0396612 Luxembourg EP 89901763.6 Granted EP 0396612 Netherlands EP 89901763.6 Granted EP 0396612 Sweden EP 89901763.6 Granted EP 0396612 Switzerland/ Liechtenstein EP 89901763.6 Granted EP 0396612 United Kingdom EP 89901763.6 Granted EP 0000000 Xxxxx 501661/89 Granted 2980626 *United States 07/142,039 United States 08/472,696 5,846,818 United States 08/357,234 5,576,195 *Cases abandoned in favor of a continuing application. SCHEDULE 2.2 Transfer of XOMA Materials [*] SCHEDULE 2.9 Third Parties and Activities [*] SCHEDULE 3.3 Dyax Materials [*] SCHEDULE 5.2 Redacted Agreement

Appears in 1 contract

Samples: License Agreement (Dyax Corp)

Patent No. Australia 23244/88 Issued 632,462 Austria EP 88907510.7 Granted EP/0371998 Belgium EP 88907510.7 Granted EP/0371998 Canada 572,398 Pending Granted 1,341,235 Denmark 192/90 Pending Europe EP 88907510.7 XX 00000000.7 Granted EP/0371998 Europe EP 95119798.7 Pending (divisional) Granted EP/0731167 France EP 88907510.7 Granted EP/0371998 Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0000000 EP/0371998 Japan 506481/88 Pending Grantex 0000020 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 * Cases abandoned in favor of a continuing application.-33-

Appears in 1 contract

Samples: License Agreement (Xoma LTD /De/)

Patent No. Australia 23244/88 Issued 632,462 Austria EP 88907510.7 Granted EP/0371998 Belgium EP 88907510.7 Granted EP/0371998 Canada 572,398 Pending Denmark 192/90 Pending Europe EP 88907510.7 Granted EP/0371998 Europe EP 95119798.7 Pending Allowed (divisional) France EP 88907510.7 Granted EP/0371998 Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0000000 Japan 506481/88 Pending Granted 2991720 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/ Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998 Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Xxxxxxxxxx Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 * Cases abandoned in favor of a continuing application.EP/0550400

Appears in 1 contract

Samples: Non Exclusive License Agreement (Viventia Biotech Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.